Wheelsbridge AB develops, manufactures and brings to market technologies for quantification of skin erythema and other skin parameters.
The Tissue Viability Imager TiVi700 2.0 (TiVi) is based on the principles of polarization spectroscopy imaging and facilitates objective assessment of the safety and efficacy of novel skin care products in the development and validation phase.
In addition to creating maps of skin microcirculation TiVi is now also equipped with software extensions for assessment of:
Quantitative assessment of comedones.
Upper left: baseline photo | Lower left: endpoint
Upper right: number of spots versus photo number | Lower right: number of spots versus spot size
www.wheelsbridge.com | Corporate and testing sheet: https://skinobs.com/instrumentation.php?id=109
Read the entire ZOOM#23 here
Phone: +46 708-765-190
E-mail: info@wheelsbridge.se
The FOCUS #11 is here, with all you need to know about expert discussion around…
There will be two separate devices: an environmental sensor and a biomarker sensor. COPD- and…
Our team has a lot to share about South Asian markets! Key figures, key facts…
